Food and Drug Administration
Center for Drug Evaluation and Research
Endocrinologic and Metabolic Drugs Advisory Committee
Holiday Inn Bethesda
8120 Wisconsin Avenue, Bethesda, MD
July 27, 2001
NDA 21-318, FortéoTM (teriparatide injection, rDNA origin) Eli Lilly and Company
Special Government Employee Consultants
Acting Chair:
Mark E. Molitch, M.D.
Professor of Medicine
Northwestern University Medical School
Center for Endocrinology, Metabolism and Molecular Medicine
303 East Chicago Avenue
Tarry Building., Room 15-731
Chicago, Illinois 60611
Robert A. Kreisberg, M.D.
Dean, School of Medicine
University of South Alabama
307 University Boulevard, Rm. 170 CSAB
Mobile, Alabama 36688
Risk Management Consultant:
Eric S. Holmboe, M.D., FACP
Yale University School of Medicine
1074 LMP
333 Center Street
New Haven, CT 06510
Consumer Representative:
Jody L. Pelosi, F.N.P., Ph.D.
Phoenix Indian Medical Center
4212 North 16th Street
Phoenix, AZ 85016
Guest:
Henry G. Bone III, M.D.
Director, Michigan Bone and Mineral Clinic
22201 Moross Road, Suite 260
Detroit, Michigan 48236